Clinicopathologic features, surgical treatments and outcomes of small bowel tumors

Introduction: Small bowel tumor is a rare disease, mainly malignant, with diverse clinical morphology. This study aims to describe the clinical, para-clinical morphology, pathology, and early outcomes of surgical treatment for patients with small bowel tumor at Viet Duc University Hospital. Patients and methods: Descriptive retrospective study, patients with small bowel tumors were operated at Viet Duc University Hospital from January 2015 to December 2020. Results: 64 patients (mean age 54.12 ± 15.49, 30 men, 34 women) underwent surgery at Viet Duc University Hospital from January 2015 to December 2020. Acute form: 32.1%. Chronic clinical forms: 62.5%. Malignant tumors account for 52/64 cases (81.2%) while GISTs intermediate risk- high risk accounted for 61.5% mainly. The percentage of small bowel resection was 89.1%. There was no other postoperative complication, except one case of postoperative death. The survival time after surgery was 58.82±3.04 months, the best case was GIST 61 months, the worst was Adenocarcinoma 6 months. Conclusion: Small bowel tumor is a rare disease, mostly malignant at the middle age with silent progression, often detected when the disease at a last stage. GIST accounts for the high proportion (57.8%) with positive treatment results.